F. Mulero

Metabolic synthetic lethality: a randomized, phase 0/I trial of the mitochondrial inhibitor ME-344 or placebo added to bevacizumab in early HER2-negative breast cancer.

Gion, S. Morales, J. Cortés, 2019 .

Doppler ultrasonographic and scintigraphic assessment of an auxiliary heterotopic liver transplantation with portal vein arterialization in pigs.

P. Parrilla, A. Ríos, P. Ramírez, 2006, Transplantation proceedings.

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging

L. A. Fernández, J. Martínez-Torrecuadrada, R. Campos-Olivas, 2022, Frontiers in Medicine.

SPECT Radiomics: The Current Landscape, Challenges, and Opportunities

F. Shaikh, F. Mulero, 2021, Clinical Applications of SPECT-CT.